Science Corporation implants its vision-restoring chip in its first Stargardt disease patient
Max Hodak, the former president and co-founder of Neuralink, detailed on stage at TechCrunch Disrupt how his company's work with PRIMA is part of its path toward a novel brain-computer interface (BCI).
The latest reports regarding "Science Corporation implants its vision-restoring chip in its first Stargardt disease patient" indicate a significant shift in the current situation. Experts are closely monitoring the developments as more data becomes available from official sources. This story is still developing and impact assessments are underway.
Observers suggest that this event could have long-term implications for the tech sector. Stay tuned as we bring you further updates and exclusive footage regarding these recent changes. Our team is working to verify additional details from the ground.
- Live Update: Cut screen time in classrooms to avoid long-term health issues, clinicians urge
- Live Update: Niobia takes the guesswork out of some of tech’s most expensive mistakes
- Live Update: Laplace Intelligence red-teams robots and self-driving cars before they hit the real world
- Live Update: Three things we've learnt about the UK economy from the IMF
- Live Update: Russia's offensive ability is broken, Kyiv's former top general tells BBC
- Despite long history with Netanyahu, Trump hedges as Israel vote nears
- Live Update: Russia's offensive ability is broken, Kyiv's former top general tells BBC
No comments:
Post a Comment